Antal Nemeth

Antal Nemeth

Auto-generated profile, based on publicly available information

Antal Nemeth

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1998 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SSSandra S. Strautnieks
Sandra S. Strautnieks
LBLaura N. Bull
Laura N. Bull
AKAlexander S. Knisely
Alexander S. Knisely
SKSamuel A. Kocoshis
Samuel A. Kocoshis
NDNiklas Dahl
Niklas Dahl
RTRichard J. Thompson
Richard J. Thompson

1 April 2008 in Gastroenterology
Verified
Journal Article
Open access
PDF file
SSSandra S. Strautnieks
Sandra S. Strautnieks
JBJane A. Byrne
Jane A. Byrne
LPLudmila Pawlikowska
Ludmila Pawlikowska
DCDita Cebecauerová
Dita Cebecauerová
ARAnne Rayner
Anne Rayner
RTRichard J. Thompson
Richard J. Thompson
Background & Aims: Patients with severe bile salt export pump (BSEP) deficiency present as infants with progressive cholestatic liver disease. We characterized mutations of ABCB11 (encoding BSEP) in such patients and correlated genotypes with residual protein detection and risk of malignancy. Methods: Patients with intrahepatic cholestasis suggestive of BSEP deficiency were investigated by single-strand conformation polymorphism analysis and sequencing of ABCB11. Genotypes sorted by likely phenotypic severity were correlated with data on BSEP immunohistochemistry and clinical outcome. Results: Eighty-two different mutations (52 novel) were identified in 109 families (9 nonsense mutations, 10 small insertions and deletions, 15 splice-site changes, 3 whole-gene deletions, 45 missense changes). In 7 families, only a single heterozygous mutation was identified despite complete sequence analysis. Thirty-two percent of mutations occurred in >1 family, with E297G and/or D482G present in 58% of European families (52/89). On immunohistochemical analysis (88 patients), 93% had abnormal or absent BSEP staining. Expression varied most for E297G and D482G, with some BSEP detected in 45% of patients (19/42) with these mutations. Hepatocellular carcinoma or cholangiocarcinoma developed in 15% of patients (19/128). Two protein-truncating mutations conferred particular risk; 38% (8/21) of such patients developed malignancy versus 10% (11/107) with potentially less severe genotypes (relative risk, 3.7 [confidence limits, 1.7–8.1; P = .003]). Conclusions: With this study, >100 ABCB11 mutations are now identified. Immunohistochemically detectable BSEP is typically absent, or much reduced, in severe disease. BSEP deficiency confers risk of hepatobiliary malignancy. Close surveillance of BSEP-deficient patients retaining their native liver, particularly those carrying 2 null mutations, is essential.

26 July 2006 in Hepatology
Verified
Journal Article
Closed access
PDF file
AKA. S. Knisely
A. S. Knisely
SSSandra S. Strautnieks
Sandra S. Strautnieks
YMYvonne Meier
Yvonne Meier
BSBruno Stieger
Bruno Stieger
JBJane A. Byrne
Jane A. Byrne
RTRichard J. Thompson
Richard J. Thompson

1 July 1996 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MRM. Riepenhoff-Talty
M. Riepenhoff-Talty
VGV. Gouvea
V. Gouvea
MEM. J. Evans
M. J. Evans
LSL. Svensson
L. Svensson
EHE. Hoffenberg
E. Hoffenberg
TRT. Rossi
T. Rossi
The purpose of this retrospective study was to examine liver tissue from patients with cholestatic disease for the presence of group C rotavirus RNA. The reverse transcriptase-polymerase chain reaction (PCR) for genes 5 and 6 was used, and the PCR products were subjected to liquid hybridization with a 32P-Iabeled probe. A second amplification with nested primers was also used. Samples from 32 subjects (20 with biliary atresia or choledochal cyst and 12 controls) were tested. Ten of 20 biliary atresia patients were positive for group C rotavirus RNA; no controls were positive (P < .003). Three of the positive patients were positive for both genes 5 and 6. Six of the 10 had >1 sample that was positive. These data suggest a possible relationship between group C rotavirus and extrahepatic biliary atresia in the 10 patients in whom virus RNA was detected.

1 July 2010 in Journal of Hepatology
Verified
Journal Article
Closed access
LPLudmila Pawlikowska
Ludmila Pawlikowska
SSSandra Strautnieks
Sandra Strautnieks
IJIrena Jankowska
Irena Jankowska
PCPiotr Czubkowski
Piotr Czubkowski
KEKaran Emerick
Karan Emerick
LBLaura N. Bull
Laura N. Bull

1 July 1998 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
BFBjörn Fischler
Björn Fischler
AEAnneka Ehrnst
Anneka Ehrnst
MFMarianne Forsgren
Marianne Forsgren
CÖClaes Örvell
Claes Örvell
ANAntal Nemeth
Antal Nemeth